PROBLEM TO BE SOLVED: To provide a method of effectively extending progression free survival of a patient diagnosed with ovarian cancer in which administration of a chemotherapeutically effective amount of an anti-VEGF antibody is continued.SOLUTION: An anti-angiogenesis therapy for treatment of ovarian cancer comprises co-administering a monoclonal anti-VEGF (vascular endothelial growth factor) antibody and a chemotherapeutic agent such as taxane, carboplatin or gemcitabine.SELECTED DRAWING: None【課題】化学療法有効量の抗ＶＥＧＦ抗体の投与を続ける卵巣癌と診断された患者の無進行生存を効果的に延長する方法の提供。【解決手段】モノクローナル抗ＶＥＧＦ（血管内皮増殖因子）抗体とタキサン、カルボプラチンやゲムシタビン等の化学療法剤を併用投与する卵巣癌の治療のための抗血管新生療法。【選択図】なし
